Rubbert-Roth A - Search Results

1

Antigen-presenting human B cells are expanded in inflammatory conditions.

Shimabukuro-Vornhagen A, García-Márquez M, Fischer RN, Iltgen-Breburda J, Fiedler A, Wennhold K, Rappl G, Abken H, Lehmann C, Herling M, Wolf D, Fätkenheuer G, Rubbert-Roth A, Hallek M, Theurich S, von Bergwelt-Baildon M. Shimabukuro-Vornhagen A, et al. J Leukoc Biol. 2017 Feb;101(2):577-587. doi: 10.1189/jlb.5A0416-182R. Epub 2016 Aug 17. J Leukoc Biol. 2017. PMID: 27534894

2

[Rheumatic diseases in 2009: the conflict between medical progress and reality].

Rubbert-Roth A. Rubbert-Roth A. Dtsch Med Wochenschr. 2009 Sep;134(36):1733. doi: 10.1055/s-0029-1234007. Epub 2009 Aug 28. Dtsch Med Wochenschr. 2009. PMID: 19718593 German. No abstract available.

3

[Discontinuation of biologicals in rheumatoid arthritis after acquiring remission? Yes].

Rubbert-Roth A. Rubbert-Roth A. Dtsch Med Wochenschr. 2011 Aug;136(33):1674. doi: 10.1055/s-0031-1281573. Epub 2011 Aug 10. Dtsch Med Wochenschr. 2011. PMID: 21833889 German. No abstract available.

4

Spectrum of Uveitis in A German Tertiary Center: Review of 474 Consecutive Patients.

Grajewski RS, Caramoy A, Frank KF, Rubbert-Roth A, Fätkenheuer G, Kirchhof B, Cursiefen C, Heindl LM. Grajewski RS, et al. Ocul Immunol Inflamm. 2015 Aug;23(4):346-352. doi: 10.3109/09273948.2014.1002567. Epub 2015 Mar 11. Ocul Immunol Inflamm. 2015. PMID: 25760917

5

Successful use of rituximab in a patient with Churg-Strauss syndrome and refractory central nervous system involvement.

Saech J, Owczarczyk K, Rösgen S, Petereit H, Hallek M, Rubbert-Roth A. Saech J, et al. Ann Rheum Dis. 2010 Jun;69(6):1254-5. doi: 10.1136/ard.2009.109850. Epub 2009 Sep 9. Ann Rheum Dis. 2010. PMID: 19740901 No abstract available.

6

TRU-015, a fusion protein derived from an anti-CD20 antibody, for the treatment of rheumatoid arthritis.

Rubbert-Roth A. Rubbert-Roth A. Curr Opin Mol Ther. 2010 Feb;12(1):115-23. Curr Opin Mol Ther. 2010. PMID: 20140823 Review.

7

Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein (a) levels in human subjects with rheumatoid diseases.

Schultz O, Oberhauser F, Saech J, Rubbert-Roth A, Hahn M, Krone W, Laudes M. Schultz O, et al. PLoS One. 2010 Dec 13;5(12):e14328. doi: 10.1371/journal.pone.0014328. PLoS One. 2010. PMID: 21179199 Free PMC article.

8

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.

Alexander T, Sarfert R, Klotsche J, Kühl AA, Rubbert-Roth A, Lorenz HM, Rech J, Hoyer BF, Cheng Q, Waka A, Taddeo A, Wiesener M, Schett G, Burmester GR, Radbruch A, Hiepe F, Voll RE. Alexander T, et al. Ann Rheum Dis. 2015 Jul;74(7):1474-8. doi: 10.1136/annrheumdis-2014-206016. Epub 2015 Feb 20. Ann Rheum Dis. 2015. PMID: 25710470 Free PMC article. Clinical Trial.

9

Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.

Petereit HF, Rubbert-Roth A. Petereit HF, et al. Mult Scler. 2009 Feb;15(2):189-92. doi: 10.1177/1352458508098268. Epub 2008 Oct 29. Mult Scler. 2009. PMID: 18971221 Clinical Trial.

10

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.

Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM; IMAGE Investigators. Tak PP, et al. Ann Rheum Dis. 2011 Jan;70(1):39-46. doi: 10.1136/ard.2010.137703. Epub 2010 Oct 11. Ann Rheum Dis. 2011. PMID: 20937671 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters